Genomics shows great promise for cardiovascular health.   Now that the Food and Drug Administration (FDA) has approved 23 and me for consumer use to clarify heritable health and disease risks, individuals and families will want to know more about genomics.  Significant aspects of genomics lead more to nutritional than pharmaceutical solutions for health and wellbeing.  Heart health concerns point to these nutrigenomic strategies for personalized health.  Dr. Jonas will review the role of nutrigenomics, methylation, epigenetics, the microbiome and the autonomic nervous system for wholehearted health.